Full-Time

Sr. Applied Research Scientist

Posted on 9/19/2024

Radformation

Radformation

51-200 employees

Healthcare software for radiation therapy planning

AI & Machine Learning
Healthcare

Compensation Overview

$170k - $200kAnnually

Senior

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Deep understanding of traditional dose calculation methods (Pencil Beam, CVSP, etc).
  • Able to formulate experiment design and run experiments while developing new algorithms and technology.
  • Able to stay current with state-of-the-art algorithmic techniques.
  • Experience conceiving, implementing, and maintaining clinically used software solutions.
Responsibilities
  • Take technical ownership of Radformation proprietary dose calculation algorithms.
  • Work with research and product teams to create new radiotherapy products and algorithms.
  • Test and benchmark Radformation proprietary algorithms against industry standard algorithms.

Radformation provides software tools that improve the treatment planning process for radiation therapy in healthcare. Their products, which are FDA-cleared, include ClearCheck for automating plan checks, ClearCalc for dose validation, EZFluence for creating 3D treatment plans, AutoContour for AI-driven contouring, ChartCheck for monitoring patient data in real-time, and QuickCode for billing quality assurance. These tools integrate into existing workflows at clinics and healthcare providers, helping to save time and resources while ensuring high-quality patient care. Radformation stands out from competitors by focusing on automation and efficiency in radiation oncology, aiming to enhance the overall quality of treatment planning.

Company Stage

Seed

Total Funding

$8.9M

Headquarters

New York City, New York

Founded

2016

Growth & Insights
Headcount

6 month growth

11%

1 year growth

78%

2 year growth

82%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Limbus AI enhances Radformation's AI capabilities in radiation therapy.
  • Regulatory clearances in multiple countries indicate global acceptance and growth potential.
  • Partnership with Icon Group expands market reach and improves cancer care workflows.

What critics are saying

  • Emerging AI-driven startups may challenge Radformation's market position with competitive solutions.
  • Rapid technological advancements require continuous R&D investment to maintain competitiveness.
  • Economic instability in key markets could impact Radformation's sales and expansion plans.

What makes Radformation unique

  • Radformation offers FDA-cleared software tools for radiation therapy workflow automation.
  • Their AI-driven solutions enhance treatment planning efficiency and accuracy in cancer care.
  • Radformation's products integrate seamlessly into existing clinical workflows, saving time and resources.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE